{"data":{"type":"company_profile_ai","id":151867,"entity_id":"wefunder:company:151867","attributes":{"canonical_url":"https://wefunder.com/global.cancer.technology","retrieval_urls":{"canonical":"https://wefunder.com/global.cancer.technology","json":"https://wefunder.com/global.cancer.technology.json","markdown":"https://wefunder.com/global.cancer.technology.md","ai_json":"https://wefunder.com/global.cancer.technology.ai.json","ai_text":"https://wefunder.com/global.cancer.technology.ai.txt","changelog_json":"https://wefunder.com/global.cancer.technology.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-06-04T23:53:55Z","generated_at":"2026-06-05T21:12:20Z","profile_visibility":{"owner_published":true,"public_search_results":true,"site_search_listed":true,"privacy_mode":"promote","invite_only":false},"company":{"id":151867,"entity_id":"wefunder:company:151867","slug":"global.cancer.technology","name":"Global Cancer Technology","tagline":"Developing a novel drug to treat glioblastoma brain cancer and triple-negative breast cancer","location":"San Diego, CA","website":"https://globalcancertechnology.com","total_amount_raised":0,"total_investors":0,"is_funded":false,"is_active":false},"key_claims":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 0","citation":"https://wefunder.com/global.cancer.technology#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T23:53:55Z","as_of":"2026-06-05T21:12:20Z","confidence":"high"},"observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-05T23:53:55Z"},{"claim_id":"claim-total-investors","text":"Total investors: 0","citation":"https://wefunder.com/global.cancer.technology#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T23:53:55Z","as_of":"2026-06-05T21:12:20Z","confidence":"high"},"observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-05T23:53:55Z"}],"verified_facts":[{"claim_id":"claim-total-raised","text":"Total raised on Wefunder: 0","citation":"https://wefunder.com/global.cancer.technology#claim-total-raised","provenance":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T23:53:55Z","as_of":"2026-06-05T21:12:20Z","confidence":"high"},"observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-05T23:53:55Z"},{"claim_id":"claim-total-investors","text":"Total investors: 0","citation":"https://wefunder.com/global.cancer.technology#claim-total-investors","provenance":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T23:53:55Z","as_of":"2026-06-05T21:12:20Z","confidence":"high"},"observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-05T23:53:55Z"}],"company_claims":{"tagline":"Developing a novel drug to treat glioblastoma brain cancer and triple-negative breast cancer","quick_facts":["We have shown that our drug can make glioblastoma tumors completely disappear in lab mice","Research partners are Baylor University, Brown, University of Colorado , Mayo clinic and others","We have been prove equal to better than a similar drug entering a phase 111 clinical trial","Research will soon show us as the leading promising drug for children's glioblastoma, or DIPG","Preclinical studies have shown us to outperform Alpelisib, a breast cancer FDA-approved drug","Outstanding Scientific and Business advisory board"]},"computed_metrics":{"total_amount_raised":0,"total_investors":0,"team_size":1,"featured_investor_count":10,"faq_count":0,"recent_post_count":0},"quick_facts":[{"claim_id":"claim-fact-1","value":"We have shown that our drug can make glioblastoma tumors completely disappear in lab mice","citation":"https://wefunder.com/global.cancer.technology#claim-fact-1","observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-11T23:53:55Z"},{"claim_id":"claim-fact-2","value":"Research partners are Baylor University, Brown, University of Colorado , Mayo clinic and others","citation":"https://wefunder.com/global.cancer.technology#claim-fact-2","observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-11T23:53:55Z"},{"claim_id":"claim-fact-3","value":"We have been prove equal to better than a similar drug entering a phase 111 clinical trial","citation":"https://wefunder.com/global.cancer.technology#claim-fact-3","observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-11T23:53:55Z"},{"claim_id":"claim-fact-4","value":"Research will soon show us as the leading promising drug for children's glioblastoma, or DIPG","citation":"https://wefunder.com/global.cancer.technology#claim-fact-4","observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-11T23:53:55Z"},{"claim_id":"claim-fact-5","value":"Preclinical studies have shown us to outperform Alpelisib, a breast cancer FDA-approved drug","citation":"https://wefunder.com/global.cancer.technology#claim-fact-5","observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-11T23:53:55Z"},{"claim_id":"claim-fact-6","value":"Outstanding Scientific and Business advisory board","citation":"https://wefunder.com/global.cancer.technology#claim-fact-6","observed_at":"2026-06-04T23:53:55Z","expires_at":"2026-06-11T23:53:55Z"}],"latest_fundraise":{"id":109015,"entity_id":"wefunder:fundraise:109015","state":"open","offering_type":"4(a)(6)","structure":"ttw","testing_the_waters":true,"can_invest_now":true,"funding_started_at":null,"funding_closed_at":null},"investor_memos":[],"team":[{"id":4155466,"entity_id":"wefunder:company_role:4155466","name":"John Clark","title":"Founder \u0026 CEO","role":"founder","profile_url":"https://wefunder.com/john.clark.14"}],"featured_investors":[{"id":7920,"entity_id":"wefunder:company_investor_profile:7920","name":"Dr. Azik Wolf","bio":"MD-South Flordia Neurosurgeon and Internationaly renowned radiosurgery","profile_url":"https://wefunder.com/azik.wolf.mdsouth.flordia.neurosurgeon.and.internationaly.renowned.radiosurgery"},{"id":7991,"entity_id":"wefunder:company_investor_profile:7991","name":"Dr. Richard Abrahamson","bio":"MD- Optomologist-Saint Elizebeth Hospitals","profile_url":"https://wefunder.com/richard.abrahamson"},{"id":7992,"entity_id":"wefunder:company_investor_profile:7992","name":"Dr. Lance S. Cassell","bio":"MD- Pain Medicine Specialist and Accredited Investor","profile_url":"https://wefunder.com/lance.s.cassell"},{"id":7993,"entity_id":"wefunder:company_investor_profile:7993","name":"Dr. Randy Davis","bio":"DO -Internal Medicine","profile_url":"https://wefunder.com/randy.davis.1"},{"id":7994,"entity_id":"wefunder:company_investor_profile:7994","name":"Dr. Ekokobe Fonkem","bio":"DO-Chair of Neurology-Medical College of Wisconsin","profile_url":"https://wefunder.com/ekokobe.fonkem"},{"id":7995,"entity_id":"wefunder:company_investor_profile:7995","name":"Dr. Na Tosha Gatson","bio":"MD-Radiation Oncologist","profile_url":"https://wefunder.com/na.tosha.gatson"},{"id":7996,"entity_id":"wefunder:company_investor_profile:7996","name":"Dr. Mark Goldberger","bio":"DO-Neurosurgeon","profile_url":"https://wefunder.com/mark.goldberger"},{"id":7997,"entity_id":"wefunder:company_investor_profile:7997","name":"Dr. Nader Hanna","bio":"MD-Surgical Oncologist","profile_url":"https://wefunder.com/nader.hanna"},{"id":7998,"entity_id":"wefunder:company_investor_profile:7998","name":"Dr. Jason Huang","bio":"MD-Neurosurgeon-Department Chair,Baylor Scott \u0026amp; White","profile_url":"https://wefunder.com/jason.huang.3"},{"id":7999,"entity_id":"wefunder:company_investor_profile:7999","name":"Dr. Daniel Kantor","bio":"MD-President, Florida Society of Neurology","profile_url":"https://wefunder.com/daniel.kantor"}],"relationships":[{"source_entity_id":"wefunder:company:151867","relation":"has_team_member","target_entity_id":"wefunder:user:4220891","target_url":"https://wefunder.com/john.clark.14"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11402","target_url":"https://wefunder.com/azik.wolf.mdsouth.flordia.neurosurgeon.and.internationaly.renowned.radiosurgery"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11457","target_url":"https://wefunder.com/richard.abrahamson"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11479","target_url":"https://wefunder.com/lance.s.cassell"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11480","target_url":"https://wefunder.com/randy.davis.1"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11481","target_url":"https://wefunder.com/ekokobe.fonkem"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11482","target_url":"https://wefunder.com/na.tosha.gatson"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11483","target_url":"https://wefunder.com/mark.goldberger"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11484","target_url":"https://wefunder.com/nader.hanna"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11485","target_url":"https://wefunder.com/jason.huang.3"},{"source_entity_id":"wefunder:company:151867","relation":"has_featured_investor","target_entity_id":"wefunder:notable_investor:11486","target_url":"https://wefunder.com/daniel.kantor"},{"source_entity_id":"wefunder:company:151867","relation":"has_latest_fundraise","target_entity_id":"wefunder:fundraise:109015"}],"faq":[],"recent_posts":[],"provenance":{"source":"wefunder_public_company_profile","as_of":"2026-06-05T21:12:20Z","claims":{"total_amount_raised":{"source":"FrontCompanySummary#amount_raised","last_verified_at":"2026-06-04T23:53:55Z","as_of":"2026-06-05T21:12:20Z","confidence":"high"},"total_investors":{"source":"FrontCompanySummary#number_of_investors","last_verified_at":"2026-06-04T23:53:55Z","as_of":"2026-06-05T21:12:20Z","confidence":"high"},"active_raise_states":{"source":"Fundraise.visible(nil, nil)","last_verified_at":"2026-05-12T22:02:06Z","as_of":"2026-06-05T21:12:20Z","confidence":"high"},"latest_fundraise_state":{"source":"Fundraise.visible(nil, nil).order(funding_started_at)","last_verified_at":"2026-05-12T22:02:06Z","as_of":"2026-06-05T21:12:20Z","confidence":"medium"}}}}}}